• HOME
  • QUIZ
  • CONTACT US
EXAMIANS
  • COMPUTER
  • CURRENT AFFAIRS
  • ENGINEERING
    • Chemical Engineering
    • Civil Engineering
    • Computer Engineering
    • Electrical Engineering
    • Mechanical Engineering
  • ENGLISH GRAMMAR
  • GK
  • GUJARATI MCQ

Current Affairs - July 2020

Current Affairs - July 2020
Which country recently approved Dexamethasone as a second treatment of COVID-19?

India
China
Japan
USA

ANSWER DOWNLOAD EXAMIANS APP

Current Affairs - July 2020
Who will chaired the committee by SEBI regarding matter related to Mutual Funds Industries?

Usha Thorat
Ajit Malik
K K Mishra
Ram,esh Chauhan

ANSWER DOWNLOAD EXAMIANS APP

Current Affairs - July 2020
The world's largest COVID care centre has been inaugurated in which Indian state/UT?

Gujarat
Maharashtra
New Delhi
Madhya Pradesh

ANSWER DOWNLOAD EXAMIANS APP

Current Affairs - July 2020
Who has been appointed as the new Chief Secretary of Rajasthan replacing incumbent D.B. Gupta in the bureaucratic reshuffle amid COVID-19 pandemic?

Samant Goel
Rajeeva Swarup
Anil Kumar Gupta
Rajiv Gauba

ANSWER DOWNLOAD EXAMIANS APP

Current Affairs - July 2020
As per Lancet journal, the potential Covid-19 vaccine developed by which institution has produced strong immune response ?

Yale University
Oxford University
Stanford University
Harvad University

ANSWER DOWNLOAD EXAMIANS APP

Current Affairs - July 2020
Who is chairman of 9- member working group formed by IRDAI to look into the possibility of setting up 'Pandemic Risk Pool' to deal with the various risks arising out of a pandemic?

Karnam Sekar
Ravneet Gill
Sandeep Bakhshi
Suresh Mathur

ANSWER DOWNLOAD EXAMIANS APP
MORE MCQ ON Current Affairs - July 2020

DOWNLOAD APP

  • APPLE
    from app store
  • ANDROID
    from play store

SEARCH

LOGIN HERE


  • GOOGLE

FIND US

  • 1.70K
    FOLLOW US
  • EXAMIANSSTUDY FOR YOUR DREAMS.
  • SUPPORT :SUPPORT EMAIL ACCOUNT : examians@yahoo.com

OTHER WEBSITES

  • GUJARATI MCQ
  • ACCOUNTIANS

QUICK LINKS

  • HOME
  • QUIZ
  • PRIVACY POLICY
  • DISCLAIMER
  • TERMS & CONDITIONS
  • CONTACT US
↑